IL24 and pancreatic neoplasm: Negative regulation of β-catenin and phosphatidylinositol 3-kinase (PI3K) pathways is another mechanism by which IL-24 exerts its anticancer activity in human breast, lung and pancreatic cancer cells [26,47].